SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026GuruFocus · Oct 17, 2026
Ampco-Pittsburgh Up Nearly 217% in a Year: What's Driving the Stock?Zacks Investment Research · Sep 17, 2026
Ampco-Pittsburgh Corporation to Present at the Sidoti Small-Cap Virtual Investor Conference on September 23, 2026Business Wire · Sep 16, 2026
Ampco-Pittsburgh: I'm Taking The Bait And Turning BullishSeeking Alpha · Sep 14, 2026
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe HypertriglyceridemiaGuruFocus · Aug 30, 2026
Ampco-Pittsburgh vs. NN: Which Industrial Stock Is the Better Buy?Zacks Investment Research · Aug 26, 2026Ampco-Pittsburgh Corporation, together with its subsidiaries, engages in manufacture and sale of specialty metal products and customized equipment to commercial and industrial users worldwide. The company operates through two segments: Forged and Cast Engineered Products (FCEP); and Air and Liquid Processing (ALP). The FCEP segment produces forged hardened steel rolls, cast rolls, and forged engineered products that are used in hot and cold rolling mills by producers of steel, aluminum, and other metals; cast rolls for hot strip mills, medium/heavy section mills, roughing mills, and plate mills; and forged engineered products for narrow and wide strip and aluminum mills, back-up rolls for narrow strip mills, and leveling rolls and shafts for steel distribution market, oil and gas industry, and the aluminum and plastic extrusion industries.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 11, 2026 | $0.08 | $0.07 | Miss |
| May 12, 2026 | $0.08 | -$0.04 | Miss |
| Mar 16, 2026 | $0.08 | -$0.17 | Miss |
| Nov 12, 2025 | – | $0.04 | |
| Aug 13, 2025 | – | -$0.06 | |
| May 12, 2025 | – | $0.06 |